CN111514082A - Striae gravidarum repair composition and application method thereof - Google Patents
Striae gravidarum repair composition and application method thereof Download PDFInfo
- Publication number
- CN111514082A CN111514082A CN202010405104.6A CN202010405104A CN111514082A CN 111514082 A CN111514082 A CN 111514082A CN 202010405104 A CN202010405104 A CN 202010405104A CN 111514082 A CN111514082 A CN 111514082A
- Authority
- CN
- China
- Prior art keywords
- composition
- parts
- promoting
- striae gravidarum
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 115
- 206010040925 Skin striae Diseases 0.000 title claims abstract description 42
- 230000008439 repair process Effects 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims abstract description 18
- 102000008186 Collagen Human genes 0.000 claims abstract description 19
- 108010035532 Collagen Proteins 0.000 claims abstract description 19
- 229920001436 collagen Polymers 0.000 claims abstract description 19
- 230000001737 promoting effect Effects 0.000 claims abstract description 18
- 239000008280 blood Substances 0.000 claims abstract description 7
- 210000004369 blood Anatomy 0.000 claims abstract description 7
- 239000000835 fiber Substances 0.000 claims abstract description 7
- 235000015097 nutrients Nutrition 0.000 claims abstract description 6
- 230000008929 regeneration Effects 0.000 claims abstract description 6
- 238000011069 regeneration method Methods 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 5
- 230000003213 activating effect Effects 0.000 claims abstract description 4
- 230000017531 blood circulation Effects 0.000 claims abstract description 4
- 238000005469 granulation Methods 0.000 claims abstract description 4
- 230000003179 granulation Effects 0.000 claims abstract description 4
- 230000035876 healing Effects 0.000 claims abstract description 4
- 230000001338 necrotic effect Effects 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 206010061218 Inflammation Diseases 0.000 claims abstract description 3
- 230000002159 abnormal effect Effects 0.000 claims abstract description 3
- 238000005282 brightening Methods 0.000 claims abstract description 3
- 230000003467 diminishing effect Effects 0.000 claims abstract description 3
- 230000004054 inflammatory process Effects 0.000 claims abstract description 3
- 230000006798 recombination Effects 0.000 claims abstract description 3
- 238000005215 recombination Methods 0.000 claims abstract description 3
- 230000001502 supplementing effect Effects 0.000 claims abstract description 3
- 239000003086 colorant Substances 0.000 claims abstract 2
- 210000003491 skin Anatomy 0.000 claims description 21
- 239000000284 extract Substances 0.000 claims description 19
- 240000005546 Piper methysticum Species 0.000 claims description 15
- 235000016787 Piper methysticum Nutrition 0.000 claims description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 15
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims description 12
- 208000031439 Striae Distensae Diseases 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 12
- 102400001368 Epidermal growth factor Human genes 0.000 claims description 10
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 10
- 229940116977 epidermal growth factor Drugs 0.000 claims description 10
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 10
- 229960000401 tranexamic acid Drugs 0.000 claims description 10
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 10
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 8
- 244000235603 Acacia catechu Species 0.000 claims description 8
- 235000006226 Areca catechu Nutrition 0.000 claims description 8
- 241001313857 Bletilla striata Species 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 229960000304 folic acid Drugs 0.000 claims description 6
- 235000019152 folic acid Nutrition 0.000 claims description 6
- 239000011724 folic acid Substances 0.000 claims description 6
- 229940108325 retinyl palmitate Drugs 0.000 claims description 6
- 235000019172 retinyl palmitate Nutrition 0.000 claims description 6
- 239000011769 retinyl palmitate Substances 0.000 claims description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 5
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 claims description 5
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 5
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 5
- JHGWQSGWUPCKNT-UHFFFAOYSA-N 2-tert-butyl-4-methyl-1,3,5-trinitrobenzene Chemical compound CC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C(C)(C)C)=C1[N+]([O-])=O JHGWQSGWUPCKNT-UHFFFAOYSA-N 0.000 claims description 5
- VMZJCIQOZYJFRB-UHFFFAOYSA-N 3-iodoprop-1-yn-1-ol Chemical compound OC#CCI VMZJCIQOZYJFRB-UHFFFAOYSA-N 0.000 claims description 5
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 5
- 102000015636 Oligopeptides Human genes 0.000 claims description 5
- 108010038807 Oligopeptides Proteins 0.000 claims description 5
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 5
- 240000004824 Trimezia steyermarkii Species 0.000 claims description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 5
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 5
- SKKTUOZKZKCGTB-UHFFFAOYSA-N butyl carbamate Chemical compound CCCCOC(N)=O SKKTUOZKZKCGTB-UHFFFAOYSA-N 0.000 claims description 5
- 239000009136 dragon's blood Substances 0.000 claims description 5
- 229960003639 laurocapram Drugs 0.000 claims description 5
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 5
- 235000020778 linoleic acid Nutrition 0.000 claims description 5
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 5
- 229960005323 phenoxyethanol Drugs 0.000 claims description 5
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 5
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 5
- 229920001285 xanthan gum Polymers 0.000 claims description 5
- 239000000230 xanthan gum Substances 0.000 claims description 5
- 229940082509 xanthan gum Drugs 0.000 claims description 5
- 235000010493 xanthan gum Nutrition 0.000 claims description 5
- 229940116257 pepper extract Drugs 0.000 claims description 4
- 244000153234 Hibiscus abelmoschus Species 0.000 claims description 3
- 210000001015 abdomen Anatomy 0.000 claims description 3
- 230000003444 anaesthetic effect Effects 0.000 claims description 3
- 239000007766 cera flava Substances 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 230000000249 desinfective effect Effects 0.000 claims description 3
- 210000002615 epidermis Anatomy 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000009286 sanguis draxonis Substances 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 210000001519 tissue Anatomy 0.000 claims description 3
- 241000382455 Angelica sinensis Species 0.000 claims description 2
- 150000001720 carbohydrates Chemical class 0.000 claims description 2
- 229940042585 tocopherol acetate Drugs 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims 1
- 235000020742 piper methysticum extract Nutrition 0.000 claims 1
- 229940118495 piper methysticum root extract Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 230000009471 action Effects 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 3
- 230000001976 improved effect Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 230000004044 response Effects 0.000 abstract description 2
- 244000276331 Citrus maxima Species 0.000 description 5
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 4
- 208000032544 Cicatrix Diseases 0.000 description 3
- 240000002045 Guettarda speciosa Species 0.000 description 3
- 235000001287 Guettarda speciosa Nutrition 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 3
- 229940107491 kava root Drugs 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 230000037387 scars Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 210000003195 fascia Anatomy 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- 238000002647 laser therapy Methods 0.000 description 2
- 230000001795 light effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 235000001759 Citrus maxima Nutrition 0.000 description 1
- 241000244987 Daiswa polyphylla Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- SWGJCIMEBVHMTA-UHFFFAOYSA-K trisodium;6-oxido-4-sulfo-5-[(4-sulfonatonaphthalen-1-yl)diazenyl]naphthalene-2-sulfonate Chemical compound [Na+].[Na+].[Na+].C1=CC=C2C(N=NC3=C4C(=CC(=CC4=CC=C3O)S([O-])(=O)=O)S([O-])(=O)=O)=CC=C(S([O-])(=O)=O)C2=C1 SWGJCIMEBVHMTA-UHFFFAOYSA-K 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/927—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of insects, e.g. shellac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a striae gravidarum repair composition, which comprises a composition A for supplementing nutrient substances, activating cell regeneration and promoting collagen recombination, a composition B for promoting regeneration of broken fibers, lightening color and brightening skin colors, and a composition C for diminishing inflammation, sterilizing, promoting blood circulation, removing blood stasis, removing necrotic tissue, promoting granulation and promoting healing of abnormal collagen fibers of striae gravidarum, wherein the composition comprises 1 part of composition A, 1 part of composition B and 1 part of composition C by weight. The composition A, the composition B and the composition C have the combined action, so that the repairing effect of the striae gravidarum is greatly improved, the repairing rate reaches over 90 percent, and the composition has the advantages of no pain, quick response, no side effect, low cost, acceptable cost, no relapse and short repairing period in the using process.
Description
Technical Field
The invention belongs to the technical field of striae gravidarum repair, and particularly relates to a striae gravidarum repair composition and an application method thereof.
Background
The striae gravidarum is the stretch injury and skin relaxation caused by the excessive stretching of the abdominal skin of a pregnant woman, the loss of collagen, the breakage of elastic fibers, the tearing of the subcutaneous fascia, the pigmentation caused by the stretching injury of capillary vessels and the like in the growth and development process of a fetus, so that the rupture of the fascia fibers causes the skin depression, the extrusion of the capillary vessels and the formation of scar-shaped stripes on the surface of the skin.
Striae gravidarum has serious effects on women in life, such as: the beauty of the skin is affected, skin itch and eruption are caused, fat accumulation and collapse are accompanied, the treatment is ineffective for a long time, and psychological problems are caused.
At present, the following methods are generally adopted for eliminating striae gravidarum: 1. the application method, which uses essential oil or single cream to apply the skin with striae gravidarum, needs to treat the striae gravidarum by times, has long treatment course and the best effect only can fade the stripes; 2. skin changing method: the chemical desquamating agent is mostly used with acidic materials or corrosive materials, but the skin thickness and the personal reaction degree are not fixed, so that proliferation scars are easily caused, and the large-area use of the chemical desquamating agent has adverse effects on the body; 3. the laser therapy, the common laser therapy, can only carry out punctiform treatment, needs to carry out treatment on a large area by times, is difficult to master depth, and often leaves scars; 4. the grinding method can cause pain and scars for patients after large-area treatment;
all the traditional treatment results have high cost, obvious side effect and very poor effect.
Disclosure of Invention
In order to solve the problems in the prior art, the invention aims to provide a striae gravidarum repair composition and an application method thereof.
In order to achieve the above purpose, the invention adopts the following technical scheme:
a striae gravidarum repair composition, this composition includes composition A used for supplementing nutrient substance, activating cell regeneration and promoting collagen to reorganize, composition B used for promoting the broken fiber to regenerate, lighten the color and subside and brighten the complexion and composition C of the abnormal collagen fiber healing of the anti-inflammatory sterilizing, promoting blood circulation to remove blood stasis, removing the necrotic tissue and promoting granulation, promoting the striae gravidarum, counted by weight, said composition is made up of composition A1 part, composition B1 part and composition C1 part;
the composition A comprises the following components in parts by weight:
3-5 parts of human-like collagen, 10-20 parts of tranexamic acid, 5-8 parts of EGF (epidermal growth factor), 2-3 parts of propylene glycol, 1-2 parts of butanediol, 3-4 parts of trehalose, 12-5 parts of oligopeptide, 20-40 parts of collagen extract, 5-7 parts of sodium hyaluronate, 12-5 parts of biogum carbohydrate gum, 10-20 parts of xanthan gum, 15-20 parts of kava pepper extract, 2-4 parts of phenoxyethanol, 1 part of methylisothiazolinone and 1 part of iodopropynyl alcohol butyl carbamate;
the composition B comprises the following components in parts by weight:
0.5-1 part of retinol palmitate, 10-20 parts of tranexamic acid, 10-5 parts of vitamin P3, 1-3 parts of folic acid, 3-5 parts of citric acid, 5-15 parts of vitamin C, 40-50 parts of pomelo seed oil, 10-20 parts of tocopherol acetate, 5-8 parts of linoleic acid and 4-6 parts of laurocapram;
the composition C comprises the following components in parts by weight:
10-20 parts of bletilla striata, 20-25 parts of rhizoma paridis, 10-15 parts of catechu, 5-10 parts of angelica sinensis, 5-10 parts of dragon's blood and 3-5 parts of artificial musk;
further, the kava extract includes kava leaf extract, kava root extract and kava stem extract.
Further, the preparation method of the composition C comprises the following steps: pulverizing rhizoma Bletillae, rhizoma paridis, Catechu, radix Angelicae sinensis, sanguis Draxonis and Moschus into granules, soaking in oleum Sesami for 20 hr, decocting at 90-100 deg.C to brown, filtering, adding excipient Cera flava in liquid state, filtering, bottling, cooling to below 40 deg.C, and solidifying and molding.
A method of use of a stretch mark repair composition for repairing stretch marks.
Further, the composition is used for repairing stretch marks, and specifically comprises the following steps:
a. applying anesthetic on striae gravidarum;
b. cleaning and disinfecting;
c. applying a composition A;
d. introducing the composition A by using a roller microneedle until the epidermis turns red and has tiny blood filaments;
e. applying a composition B;
f. smearing the composition C, covering with double-layer gauze, putting on a belly belt, dripping the composition A3-5 hr later, and keeping moist;
g. changing the dressing once on each of days 2, 3 and 5, and sequentially applying composition A, composition B and composition C.
In the invention, the composition A contains micromolecular component nutrient solution such as human-like collagen, EGF growth factor and the like, and the composition A is introduced into a skin basal layer through a roller needle with 3.0 specifications, and has the characteristics of rapid penetration, direct action, cell regeneration activation, metabolism acceleration and collagen recombination promotion.
After the composition A is introduced, the composition B is smeared, the composition B contains macromolecular component nutrient solution such as pomelo seed oil, and after the composition B is smeared on the skin, the composition B covers the skin surface into which the composition A is introduced, so that the skin surface is glittering and translucent, the composition A is prevented from volatilizing too fast, and the effect lasting is kept; meanwhile, the vitamin C, P and other combined nutrient solutions in the B can lighten and darken, and have the effects of brightening the skin and whitening the skin. In addition, the product contains retinol palmitate and folic acid, and has effects of activating cell, delaying aging, and tightening skin.
And finally, coating the composition C, when the composition C acts on the skin which is stimulated to redden by the roller, instantly melting beeswax serving as a forming agent in the composition C under the action of body temperature, and beginning to moisten the skin by using sesame oil containing traditional Chinese medicine components such as bletilla striata, paris polyphylla and the like, so that the effects of diminishing inflammation, sterilizing, promoting blood circulation to remove blood stasis, removing necrotic tissue and promoting granulation, stimulating granulation tissues of depressed skin, promoting the depressed skin to be smooth, and protecting and healing the wound surface are achieved.
Due to the adoption of the technical scheme, the invention can produce the following beneficial effects:
according to the invention, through the combined action of the composition A, the composition B and the composition C and the introduction of the roller micro-needle, the repairing effect of the striae gravidarum is greatly improved, and the repairing rate reaches more than 90%; the composition has the advantages of no pain, quick response, no side effect, low cost, acceptable cost, no relapse and short repair period in the using process.
Detailed Description
The technical solution of the present invention will be described in further detail with reference to the following examples.
Example 1, a stretch mark repair composition consisting of 1 part composition a, 1 part composition B and 1 part composition C; the composition A comprises the following components in parts by weight:
3 parts of human-like collagen, 10 parts of tranexamic acid, 5 parts of EGF (epidermal growth factor), 2 parts of propylene glycol, 1 part of butanediol, 3 parts of trehalose, 12 parts of oligopeptide, 20 parts of collagen extract, 5 parts of sodium hyaluronate, 12 parts of bioglycose, 10 parts of xanthan gum, 15 parts of kava pepper extract, 2 parts of phenoxyethanol, 1 part of methylisothiazolinone and 1 part of iodopropynyl alcohol butyl carbamate;
the composition B comprises the following components in parts by weight:
0.5 part of retinol palmitate, 10 parts of tranexamic acid, 3 parts of vitamin P, 1 part of folic acid, 3 parts of citric acid, 5 parts of vitamin C, 40 parts of pomelo seed oil, 10 parts of tocopheryl acetate, 5 parts of linoleic acid and 4 parts of laurocapram;
the composition C comprises the following components in parts by weight:
10 parts of bletilla striata, 20 parts of rhizoma paridis, 10 parts of catechu, 5 parts of angelica, 5 parts of dragon's blood and 3 parts of artificial musk.
Example 2, a stretch mark repair composition consisting of composition A1 part, composition B1 part, and composition C1 part; the composition A comprises the following components in parts by weight:
4 parts of human-like collagen, 15 parts of tranexamic acid, 7 parts of EGF (epidermal growth factor), 3 parts of propylene glycol, 1 part of butanediol, 3 parts of trehalose, 14 parts of oligopeptide, 30 parts of collagen extract, 6 parts of sodium hyaluronate, 13 parts of bioglycose, 15 parts of xanthan gum, 18 parts of kava extract, 3 parts of phenoxyethanol, 1 part of methylisothiazolinone and 1 part of iodopropynyl alcohol butyl carbamate;
the composition B comprises the following components in parts by weight:
0.75 part of retinol palmitate, 15 parts of tranexamic acid, 4 parts of vitamin P, 2 parts of folic acid, 4 parts of citric acid, 10 parts of vitamin C, 45 parts of shaddock seed oil, 15 parts of tocopheryl acetate, 6 parts of linoleic acid and 5 parts of laurocapram;
the composition C comprises the following components in parts by weight:
15 parts of bletilla striata, 22 parts of rhizoma paridis, 13 parts of catechu, 8 parts of angelica, 8 parts of dragon's blood and 4 parts of artificial musk.
Example 3, a stretch mark repair composition consisting of composition A1 part, composition B1 part, and composition C1 part; the composition A comprises the following components in parts by weight:
5 parts of human-like collagen, 20 parts of tranexamic acid, 8 parts of growth factor EGF, 3 parts of propylene glycol, 2 parts of butanediol, 4 parts of trehalose, 15 parts of oligopeptide, 40 parts of collagen extract, 7 parts of sodium hyaluronate, 15 parts of bioglycose, 20 parts of xanthan gum, 20 parts of kava pepper extract, 4 parts of phenoxyethanol, 1 part of methylisothiazolinone and 1 part of iodopropynyl alcohol butyl carbamate;
the composition B comprises the following components in parts by weight:
1 part of retinol palmitate, 20 parts of tranexamic acid, 5 parts of vitamin P, 3 parts of folic acid, 5 parts of citric acid, 15 parts of vitamin C, 50 parts of pomelo seed oil, 20 parts of tocopheryl acetate, 8 parts of linoleic acid and 6 parts of laurocapram;
the composition C comprises the following components in parts by weight:
20 parts of bletilla striata, 25 parts of rhizoma paridis, 15 parts of catechu, 10 parts of angelica, 10 parts of dragon's blood and 5 parts of artificial musk.
In examples 1, 2 and 3, the kava extract comprises a kava leaf extract, a kava root extract and a kava stem extract, and the mass ratio of the kava leaf extract to the kava root extract to the kava stem extract is 1:1: 1.
In examples 1, 2 and 3, the preparation method of the composition C was: pulverizing rhizoma Bletillae, rhizoma paridis, Catechu, radix Angelicae sinensis, sanguis Draxonis and Moschus into granules, soaking in oleum Sesami for 20 hr, decocting at 90-100 deg.C to brown, filtering, adding excipient Cera flava in liquid state, filtering, bottling, cooling to below 40 deg.C, and solidifying and molding.
The invention relates to an application method of a striae gravidarum repair composition, which is used for repairing striae gravidarum.
The application method of the striae gravidarum repair composition specifically comprises the following steps:
a. applying anesthetic on striae gravidarum;
b. cleaning and disinfecting;
c. applying a composition A;
d. introducing the composition A by using a roller microneedle until the epidermis turns red and has tiny blood filaments;
e. applying a composition B;
f. smearing the composition C, covering with double-layer gauze, putting on a belly belt, dripping the composition A3-5 hr later, and keeping moist;
g. changing the dressing once on each of days 2, 3 and 5, and sequentially applying composition A, composition B and composition C.
In order to further verify the using effect of the invention, the trial investigation of the striae gravidarum of the population is respectively carried out, and the striae gravidarum is divided into four grades, namely A, B, C, D which are respectively as follows:
A. mild striae gravidarum
Time: within 2 months after delivery, or within 6 months-1 year of the wrinkle age;
color: lines in deep red, purple red or grape color;
length and width: the length is not more than 3cm, and the width is not more than 0.35 cm;
concave-convex: the depression was not significant.
B. Moderate striae gravidarum
Time: the age of the veins is within 1-3 years;
color: lines which are not completely changed into pink or light red;
length and width: the length is not more than 5cm, and the width is not more than 0.5 cm;
concave-convex: with a slight concavity.
C. Severe striae gravidarum
Time: 3 years after delivery, or the age of the wrinkles is more than 3-5 years;
color: the surrounding is white lines and colored pigmentation;
length and width: the length is not more than 8cm, and the width is not more than 0.8 cm;
concave-convex: the depression was pressed by hand.
D. Deep striae gravidarum
Time: the age of the veins is more than 5 years;
color: the lines are silvery white;
length and width: the length is more than 8cm, and the width is more than 0.8 cm;
concave-convex: the lines are opened by hands to form a recess, and one line protrudes under the condition of relaxation.
The test subjects are divided into 4 groups according to grades, 20 persons in each group are tried for 2 months, meanwhile, questionnaires are filled out, and finally, the results are counted.
The efficacy evaluation criteria were as follows:
the effect is shown: the striae gravidarum becomes lighter and the range is reduced by more than 50 percent;
the method has the following advantages: the striae gravidarum becomes light and the range is reduced by more than 20% and is not more than 50%;
light effect: striae gravidarum becomes pale and the range is narrowed by no more than 20%;
and (4) invalidation: striae gravidarum is not lightened and the range is not narrowed.
Total effective rate% (number of effective cases + number of effective cases)/total cases × 100%.
The results are shown in the following table:
| rank of | Total number of cases | Show effect | Is effective | Light effect | Invalidation | Total effective rate |
| A | 20 | 20 | 0 | 0 | 0 | 100% |
| B | 20 | 17 | 2 | 1 | 0 | 95% |
| C | 20 | 12 | 6 | 1 | 1 | 90% |
| D | 20 | 7 | 7 | 3 | 3 | 70% |
From the above table data, it can be seen that:
the application method of the striae gravidarum repair composition has a remarkable positive effect on the lightening and range reduction of A, B grade striae gravidarum;
for the striae gravidarum of grade C and grade D, the above table shows that the total effective rate is reduced, and the effective rate and the light rate are increased, which indicates that the more serious striae gravidarum is in the slow recovery period, but the time for applying the invention is only 2 months, and the time is short, but the invention has very significant improvement compared with the traditional striae gravidarum repairing and treating means in the whole view.
Claims (5)
1. A stretch mark repair composition, comprising: the composition comprises a composition A for supplementing nutrient substances, activating cell regeneration and promoting collagen recombination, a composition B for promoting regeneration of broken fibers, lightening color and brightening skin colors, and a composition C for diminishing inflammation, sterilizing, promoting blood circulation to remove blood stasis, removing necrotic tissue and promoting granulation and promoting healing of abnormal collagen fibers of striae gravidarum, wherein the composition comprises 1 part of composition A, 1 part of composition B and 1 part of composition C in parts by weight;
the composition A comprises the following components in parts by weight:
3-5 parts of human-like collagen, 10-20 parts of tranexamic acid, 5-8 parts of EGF (epidermal growth factor), 2-3 parts of propylene glycol, 1-2 parts of butanediol, 3-4 parts of trehalose, 12-5 parts of oligopeptide, 20-40 parts of collagen extract, 5-7 parts of sodium hyaluronate, 12-5 parts of biogum carbohydrate gum, 10-20 parts of xanthan gum, 15-20 parts of kava pepper extract, 2-4 parts of phenoxyethanol, 1 part of methylisothiazolinone and 1 part of iodopropynyl alcohol butyl carbamate;
the composition B comprises the following components in parts by weight:
0.5-1 part of retinol palmitate, 10-20 parts of tranexamic acid, 10-5 parts of vitamin P3, 1-3 parts of folic acid, 3-5 parts of citric acid, 5-15 parts of vitamin C, 40-50 parts of pomelo seed oil, 10-20 parts of tocopherol acetate, 5-8 parts of linoleic acid and 4-6 parts of laurocapram;
the composition C comprises the following components in parts by weight:
10-20 parts of bletilla striata, 20-25 parts of rhizoma paridis, 10-15 parts of catechu, 5-10 parts of angelica sinensis, 5-10 parts of dragon's blood and 3-5 parts of artificial musk.
2. The stretch mark repair composition of claim 1, wherein: the Piper methysticum extract comprises Piper methysticum leaf extract, Piper methysticum root extract, and Piper methysticum stem extract.
3. The stretch mark repair composition according to claim 1, wherein: the preparation method of the composition C comprises the following steps: pulverizing rhizoma Bletillae, rhizoma paridis, Catechu, radix Angelicae sinensis, sanguis Draxonis and Moschus into granules, soaking in oleum Sesami for 20 hr, decocting at 90-100 deg.C to brown, filtering, adding excipient Cera flava in liquid state, filtering, bottling, cooling to below 40 deg.C, and solidifying and molding.
4. A method of using a stretch mark repair composition according to any one of claims 1 to 3, wherein: the composition is used for repairing stretch marks.
5. The method of using a stretch mark repair composition according to claim 4, wherein: the composition is used for repairing striae gravidarum, and specifically comprises the following steps:
a. applying anesthetic on striae gravidarum;
b. cleaning and disinfecting;
c. applying a composition A;
d. introducing the composition A by using a roller microneedle until the epidermis turns red and has tiny blood filaments;
e. applying a composition B;
f. smearing the composition C, covering with double-layer gauze, putting on a belly belt, dripping the composition A3-5 hr later, and keeping moist;
g. changing the dressing once on each of days 2, 3 and 5, and sequentially applying composition A, composition B and composition C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010405104.6A CN111514082A (en) | 2020-05-14 | 2020-05-14 | Striae gravidarum repair composition and application method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010405104.6A CN111514082A (en) | 2020-05-14 | 2020-05-14 | Striae gravidarum repair composition and application method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111514082A true CN111514082A (en) | 2020-08-11 |
Family
ID=71912319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010405104.6A Pending CN111514082A (en) | 2020-05-14 | 2020-05-14 | Striae gravidarum repair composition and application method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111514082A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114432203A (en) * | 2022-02-23 | 2022-05-06 | 张慧姊 | Restoration formula for restoring and nourishing skin firmness for injection |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103120826A (en) * | 2012-12-14 | 2013-05-29 | 上海百华生物科技有限公司 | Skin rolling needle |
| CN103933603A (en) * | 2014-04-16 | 2014-07-23 | 广西信业生物技术有限公司 | Chitosan biological medical glue for promoting human epidermal growth and preparation method of biological medical glue |
| CN106344435A (en) * | 2016-08-26 | 2017-01-25 | 吉安市御美丽健康产业股份有限公司 | Skin protection cream capable of eliminating striae gravidarum |
| CN107095966A (en) * | 2017-06-12 | 2017-08-29 | 上海康漾生物科技有限公司 | A kind of striae of pregnancy repairs gel |
| CN110464687A (en) * | 2019-09-19 | 2019-11-19 | 温军海 | A kind of composition for repairing striae of pregnancy scar |
-
2020
- 2020-05-14 CN CN202010405104.6A patent/CN111514082A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103120826A (en) * | 2012-12-14 | 2013-05-29 | 上海百华生物科技有限公司 | Skin rolling needle |
| CN103933603A (en) * | 2014-04-16 | 2014-07-23 | 广西信业生物技术有限公司 | Chitosan biological medical glue for promoting human epidermal growth and preparation method of biological medical glue |
| CN106344435A (en) * | 2016-08-26 | 2017-01-25 | 吉安市御美丽健康产业股份有限公司 | Skin protection cream capable of eliminating striae gravidarum |
| CN107095966A (en) * | 2017-06-12 | 2017-08-29 | 上海康漾生物科技有限公司 | A kind of striae of pregnancy repairs gel |
| CN110464687A (en) * | 2019-09-19 | 2019-11-19 | 温军海 | A kind of composition for repairing striae of pregnancy scar |
Non-Patent Citations (4)
| Title |
|---|
| MAO猫美业聚宝盆: "它是去疤界的高手，烫伤疤，手术疤，妊娠纹也能治！外敷就可以", 《微信文章HTTP://MP.WEIXIN.QQ.COM/S/Z2-B_SEKG7HNN7KUALWOQQ》 * |
| 吴强等: "《医学美容应用技术技能实训教程》", 31 March 2017 * |
| 洛阳宁邦生物制药有限公司: "艾凯莲抚纹修护套盒-艾凯莲舒纹精华液", 《国产非特殊用途化妆品备案服务平台HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/FW.JSP》 * |
| 深圳爱思得美容科技有限公司: "艾凯莲®皮肤抑菌膏", 《企业标准Q/SASD 004-2009》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114432203A (en) * | 2022-02-23 | 2022-05-06 | 张慧姊 | Restoration formula for restoring and nourishing skin firmness for injection |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101678621B1 (en) | Composition comprising spicules for skin care | |
| Manchester | Tattoo removal—a new simple technique | |
| CN113318058A (en) | Collagen supplement, autologous collagen liquid for radiofrequency cosmetology, and use method and application thereof | |
| CN111728917A (en) | Skin care product and preparation method thereof | |
| CN108175740B (en) | Repair cream with effects of effectively preventing and removing striae gravidarum and preparation method thereof | |
| CN106999378B (en) | Dermatological kit comprising a composition based on hibiscus flower and brischt fruit oil | |
| CN109745618A (en) | A kind of restorative procedure of striae of pregnancy | |
| CN108743921A (en) | It is a kind of to prevent the reparation liquid and its preparation method and application that scar is formed | |
| CN108143844A (en) | For maintaining the epidermal stem cells of skin and there is the Chinese herbal medicine composition and its facial mask of multiple functions | |
| CN108904334A (en) | Scar of dispelling repairs face cream and preparation method thereof | |
| CN111514082A (en) | Striae gravidarum repair composition and application method thereof | |
| CN111840201A (en) | Anti-aging and repairing composite preparation containing stem cell factor and preparation method thereof | |
| CN104188808B (en) | A kind of nti-freckle is dispelled yellow gel and preparation method thereof | |
| CN110613643A (en) | Repair wrinkle-removing cream and preparation method thereof | |
| CN102961275A (en) | Araliaceae Acanthopanax trifoliatus ethanol extract-containing skin cosmetic | |
| CN110025508A (en) | A kind of essence cream and preparation method thereof preventing striae of pregnancy generation | |
| CN103976924B (en) | A kind of essential oils containing the blue seed stem cell medicine of Your Highness | |
| CN113925820A (en) | Skin-whitening, freckle-removing and skin-protecting composition and preparation method thereof | |
| CN111803403A (en) | Sandalwood essential oil composition | |
| CN113813221B (en) | Skin wrinkle-removing anti-aging soluble beautifying microneedle patch composition and preparation method thereof | |
| KR102486595B1 (en) | Bump Mounted Mask Pack | |
| CN113876618B (en) | Skin whitening, antioxidation soluble beauty microneedle patch composition and preparation method thereof | |
| Fernandes | A short history of skin needling | |
| Sen et al. | ARTICLE ON WOUND HEALING FOR FASTER WOUND RECOVERY BY USING PLACENTAL EXTRACT THERAPY | |
| CN116035997A (en) | Preparation process and application method of pure natural freckle-removing whitening liquid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200811 |
|
| RJ01 | Rejection of invention patent application after publication |